Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation: Therapeutic implications

Medical Science Monitor

Volumn 7, Issue 5, 2001, Pages 1066-1074

  Stefano, George B ^a   Peter, Doris ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Calcium transients; Constitutive nitric oxide synthase; Endocannabinoids; Estrogen; Estrogen receptors; Granulocytes; Monocytes; Morphine; Nitric oxide; Vascular endothelial cells

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; NITRIC OXIDE SYNTHASE;

CALCIUM CELL LEVEL; CELL ADHESION; DOWN REGULATION; ENDOTHELIUM CELL; ESTROGEN THERAPY; GRANULOCYTE; HUMAN; IMMUNOREGULATION; MENOPAUSE; MONOCYTE; REVIEW; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM; VASCULAR TISSUE;

ENDOTHELIUM, VASCULAR; ESTRADIOL; FEMALE; GRANULOCYTES; HUMANS; MONOCYTES; NEUTROPHILS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 0034813608     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: Evidence for an estrogen surface receptor
2. Estradiol-stimulated nitric oxide release in human granulocytes is dependent on intracellular calcium transients: Evidence for a cell surface estrogen receptor
3. Acute exposure of estrogen to human endothelia results in nitric oxide release mediated by an estrogen surface receptor coupled to intracellular calcium transients
4. Circulating nitrite/nitrate levels increase with follicular development: Indirect evidence for estradiol mediated NO release
5. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys
6. Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy
7. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal
8. The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women
9. Neuroimmunologic implications in coronary artery disease
10. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells
11. Induction of calcium-dependent nitric oxide synthases by sex hormones
12. Estrogen increases endothelial nitric oxide by a receptor-mediated system
13. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women
14. Acute vascular effects of estrogen in postmenopausal women
15. Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium
16. Estradiol coupling to endothelial nitric oxide production stimulates GnRH release from rat median eminence
17. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen
18. Cell membrane and nuclear receptors (ERs) originate from a single transcript: Studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells
19. Estrogen and coronary heart disease in women
20. Estrogen replacement therapy and coranary heart disease: A quantitative assessment of the epidemiologic evidence
21. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study
22. Cardiovascular mortality and noncantraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study
23. Postmenopausal use of estrogen and occlusion of coronary arteries
24. Estrogen modulates responses of atherosclerotic coronary arteries
25. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women
26. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms
27. Estrogen and the blood vessel wall
28. The vascular protective effects of estrogen
29. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries
30. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17 beta-estradiol: Role of nitric oxide and calcium-activated potassium channels
31. Effects of 17 beta-estradiol on coronary microvascular responses to endothelin-I
32. Effects of 17 beta-estradiol on rat isolated coronary and mesenteric artery tone: Involvement of nitric oxide
33. Presence of the mu3 opiate receptor in endothelial cells: Coupling to nitric oxide production and vasodilation
34. Production and physiological actions of anandamide in the vasculature of the rat kidney
35. Cryopreserved veins in myocardial revascularization: Possible mechanism for their increased failure
36. Interleukin 10 stimulation of endogenous nitric oxide release from human saphenous veins diminishes immunocyte adherence
37. Autoimmunovascular regulation: Morphine and anandamide stimulated nitric oxide release
38. Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: Endothelial implications
39. Long-term exposure of human blood vessels to HIV gp120, morphine and anandamide increases endothelial adhesion of monocytes: Uncoupling of nitric oxide
40. Regulation of the immune response by sex hormones: I. In vivo effects of estradiol and testosterone on pokeweed mitogen-induced human B-cell differentiation
41. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene
42. Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels
43. Effect of estrogens on the immune system with regard to bovine placental retention
44. Effects of 17 beta-estradiol and progesterone on migration of human monocytic THP-1 cells stimulated by minimally oxidized low-density lipoprotein in vitro
45. Estrogens and atherosclerosis
46. Effects of sex hormones on chemotaxis of human peripheral polymorphonuclear leukocytes and monocytes
47. Decrease in peripheral blood polymorphonuclear leukocyte chemotactic index in endometriosis: Role of prostaglandin E2 release
48. Physiological concentration of estradiol inhibits polymorphonuclear leukocyte chemotaxis via a receptor mediated system
49. Synthesis of nitric oxide in CNS glial cells
50. Release of endothelin from the porcine aorta-inhibition by endothelium-derived nitric acid
51. Cytokine-induced activation of the neuroendocrine stress axis persists in endotoxin-tolerant mice
52. Interleukin 1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by HIV-binding to CD4 receptor
53. In vitro effects of prepartum concentrations of oestradiol-17 beta on cell-mediated immunity and phagocytosis by porcine leukocytes
54. Effects of low doses of oestradiol, testosterone and dihydrotestosterone on the immune response of broiler chicks
55. Effects of 17beta-estradiol and progesterone on the adhesion of human monocytic THP-1 cells to human female endothelial cells exposed to minimally oxidized LDL
56. Physiological concentration of 17 beta-estradiol inhibits chemotaxis of human monocytes in response to monocyte chemotactic protein
57. 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat
58. IL-10 synergizes with multiple cytokines in enhancing HIV production in cells of monocytic lineage
59. Interleukin-10 Suppresses Human Immunodeficiency Virus-1 Replication In Vitro in Cells of the Monocyte/Macrophage Lineage
60. Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo
61. Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells
62. Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus
63. Estrogen, progesterone, and vascular reactivity: Potential cellular mechanisms
64. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes
65. Estrogen binding sites in peripheral blood monocytes and effects of danazol on their sites in vitro
66. Endothelial function in different organs
67. In vitro binding of 3H-estradiol to eosinophil and neutrophil granulocytes in various tissues (normal and neoplastic) of newborn and adult rats
68. Electrophysiological evidence for a rapid membrane action of the gonadal steroid, 17-beta-estradiol, on CA1 pyramidal neurons of the rat hippocampus
69. Indomethacin prevents increased catecholamine turn over in rat brain following systemic endotoxin challenge
70. Estradiol binding to cell surface raises cytosolic free calcium in T cells
71. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons
72. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells
73. Rapid activation of MAP kinase by estrogen in the bone cell line
74. Opioid and opiate immunoregulatory processes
75. The u3 opiate receptor subtype
76. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor
77. Endogenous morphine
78. Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in invertebrate immunocytes and microglia are mediated by nitric oxide
79. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes
80. Nitric oxide inhibits the dopamine-induced K+ current via guanylate cyclase in Aplysia neurons
81. Morphine and anandamide coupling to nitric oxide stimulated GnRH and CRF release from rat median eminence: Neurovascular regulation
82. Definitive evidence for the existence of plasticity in the external zone of the median eminence during the rat estrous cycle: Implication of neuro-glio-endothelial interactions in the GnRH release
83. Median eminence nitric oxide signaling
84. Evidence for a spontaneous nitric oxide release from the rat median eminence: Influence on gonadotropin-releasing hormone release
85. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. A prospective, observational study
86. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
87. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in post-menopausal women